{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:28:50Z","timestamp":1792056530064,"version":"4.4.0"},"reference-count":35,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Hematological consequences of novel antiseizure medications (ASMs) or combined therapies are rarely reported, especially in pediatric patients undergoing surgery for epilepsy. This study aimed to assess the prevalence and risk factors of coagulation dysfunction in this population and evaluate their relationship with intra- and postoperative bleeding.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>Three hundred ninety children who underwent surgery for epilepsy and 104 children without epilepsy who underwent nonepilepsy surgery at the authors\u2019 center were included in the study. The authors retrospectively collected and analyzed the following clinical data: sex, age, weight, course of epilepsy, antiseizure therapy, first laboratory data after admission, and transfusion-related data.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>ASMs were responsible for the higher incidence of coagulation dysfunction in pediatric epilepsy surgery patients. Low body weight (OR 0.95, 95% CI 0.92\u20130.98) and valproic acid (VPA) therapy (OR 5.13, 95% CI 3.25\u20138.22) were the most relevant factors leading to coagulation dysfunction. The most common hematological side effects of VPA were thrombocytopenia and hypofibrinogenemia, whereas low body weight was only associated with hypofibrinogenemia. Both VPA and low body weight increased the need for intra- or postoperative transfusion (p &lt; 0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Pediatric epilepsy surgery patients often take multiple ASMs, resulting in an increased incidence of coagulopathy. VPA levels and low body weight were found to be the main influential factors associated with an increased risk of coagulation dysfunction. Platelet and fibrinogen levels were the main indices that were affected. Both VPA and low body weight were relevant to additional surgery-related transfusion, necessitating the need for increased awareness of preoperative coagulopathy before pediatric epilepsy surgery.<\/jats:p>\n<jats:p>Clinical trial registration no.: NCT05675254 (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\">ClinicalTrials.gov<\/jats:ext-link>)<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2023.6.peds23196","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T04:02:00Z","timestamp":1692417720000},"page":"527-534","source":"Crossref","is-referenced-by-count":3,"title":["The prevalence and risk factors of coagulopathy in pediatric patients undergoing surgery for epilepsy"],"prefix":"10.3171","volume":"32","author":[{"given":"Renqing","family":"Zhu","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfeng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Neurology, Children\u2019s Hospital of Fudan University, Shanghai, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Children\u2019s Hospital of Shanghai, China; and"},{"name":"Department of Neurosurgery, Hainan Women and Children\u2019s Medical Center, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"4","key":"b1","series-title":"Lancet Neurol","first-page":"316","article-title":"Epilepsy in China: major progress in the past two decades","volume":"20","author":"Ding D","year":"2021","unstructured":"Ding D, Zhou D, Sander JW, Wang W, Li S, Hong Z. Epilepsy in China: major progress in the past two decades. Lancet Neurol. 2021;20(4):316\u2013326."},{"issue":"11","key":"b2","series-title":"Lancet Neurol","first-page":"1114","article-title":"Epilepsy surgery in children and adults","volume":"13","author":"Ryvlin P","year":"2014","unstructured":"Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. Lancet Neurol. 2014;13(11):1114\u20131126."},{"key":"b3","series-title":"Seizure","first-page":"217","article-title":"Long-term outcomes of surgical treatment for epilepsy in adults with regard to seizures, antiepileptic drug treatment and employment","volume":"44","author":"Malmgren K","year":"2017","unstructured":"Malmgren K, Edelvik A. Long-term outcomes of surgical treatment for epilepsy in adults with regard to seizures, antiepileptic drug treatment and employment. Seizure. 2017;44:217\u2013224."},{"issue":"1","key":"b4","series-title":"Epilepsia","first-page":"128","article-title":"Temporal lobe epilepsy surgery in children and adults: a multicenter study","volume":"62","author":"Barba C","year":"2021","unstructured":"Barba C, Cossu M, Guerrini R, . Temporal lobe epilepsy surgery in children and adults: a multicenter study. Epilepsia. 2021;62(1):128\u2013142."},{"issue":"9","key":"b5","series-title":"JAMA","first-page":"922","article-title":"Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial","volume":"307","author":"Engel J Jr","year":"2012","unstructured":"Engel J Jr, McDermott MP, Wiebe S, . Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922\u2013930."},{"issue":"6","key":"b6","series-title":"Neurosurgery","first-page":"741","article-title":"Quality of life after epilepsy surgery in children: a systematic review and meta-analysis","volume":"85","author":"Maragkos GA","year":"2019","unstructured":"Maragkos GA, Geropoulos G, Kechagias K, Ziogas IA, Mylonas KS. Quality of life after epilepsy surgery in children: a systematic review and meta-analysis. Neurosurgery. 2019;85(6):741\u2013749."},{"issue":"2","key":"b7","series-title":"J Neurosurg Pediatr","first-page":"235","article-title":"Pediatric epilepsy surgery: could age be a predictor of outcomes?","volume":"18","author":"Jenny B","year":"2016","unstructured":"Jenny B, Smoll N, El Hassani Y, . Pediatric epilepsy surgery: could age be a predictor of outcomes? J Neurosurg Pediatr. 2016;18(2):235\u2013241."},{"issue":"6","key":"b8","series-title":"Lancet Neurol","first-page":"525","article-title":"Outcomes of epilepsy surgery in adults and children","volume":"7","author":"Spencer S","year":"2008","unstructured":"Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol. 2008;7(6):525\u2013537."},{"issue":"6","key":"b9","series-title":"J Neurosurg Pediatr","first-page":"654","article-title":"Coagulation abnormalities in children undergoing epilepsy surgery","volume":"7","author":"Pacione D","year":"2011","unstructured":"Pacione D, Blei F, Devinsky O, Weiner HL, Roth J. Coagulation abnormalities in children undergoing epilepsy surgery. J Neurosurg Pediatr. 2011;7(6):654\u2013659."},{"issue":"7","key":"b10","series-title":"Epilepsia","first-page":"1136","article-title":"Valproate-associated coagulopathies are frequent and variable in children","volume":"47","author":"Gerstner T","year":"2006","unstructured":"Gerstner T, Teich M, Bell N, . Valproate-associated coagulopathies are frequent and variable in children. Epilepsia. 2006;47(7):1136\u20131143."},{"issue":"6","key":"b11","series-title":"Epilepsia","first-page":"1098","article-title":"Hematologic manifestations of long-term valproate therapy","volume":"34","author":"May RB","year":"1993","unstructured":"May RB, Sunder TR. Hematologic manifestations of long-term valproate therapy. Epilepsia. 1993;34(6):1098\u20131101."},{"issue":"4","key":"b12","series-title":"CNS Neurol Disord Drug Targets","first-page":"316","article-title":"Hematological consequences of valproic acid in pediatric patients: a systematic review with a mechanistic approach","volume":"21","author":"Riahi-Zanjani B","year":"2022","unstructured":"Riahi-Zanjani B, Delirrad M, Fazeli-Bakhtiyari R, . Hematological consequences of valproic acid in pediatric patients: a systematic review with a mechanistic approach. CNS Neurol Disord Drug Targets. 2022;21(4):316\u2013325."},{"key":"b13","series-title":"Pediatr Neurol","first-page":"25","article-title":"Valproic acid-induced coagulopathy","volume":"98","author":"Kumar R","year":"2019","unstructured":"Kumar R, Vidaurre J, Gedela S. Valproic acid-induced coagulopathy. Pediatr Neurol. 2019;98:25\u201330."},{"issue":"3","key":"b14","series-title":"J Epilepsy","first-page":"142","article-title":"Valproate and epilepsy surgery","volume":"6","author":"Ranganathan C","year":"1993","unstructured":"Ranganathan C, Verma NP, Diaz FG. Valproate and epilepsy surgery. J Epilepsy. 1993;6(3):142\u2013144."},{"issue":"2","key":"b15","series-title":"Epilepsia","first-page":"141","article-title":"Sodium valproate, platelet dysfunction, and bleeding","volume":"22","author":"Loiseau P","year":"1981","unstructured":"Loiseau P. Sodium valproate, platelet dysfunction, and bleeding. Epilepsia. 1981;22(2):141\u2013146."},{"issue":"5","key":"b16","series-title":"Blood Coagul Fibrinolysis","first-page":"375","article-title":"High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study","volume":"19","author":"Koenig S","year":"2008","unstructured":"Koenig S, Gerstner T, Keller A, Teich M, Longin E, Dempfle CE. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study. Blood Coagul Fibrinolysis. 2008;19(5):375\u2013382."},{"issue":"2","key":"b17","series-title":"PLoS One","first-page":"e0264351","article-title":"Assessment of need for hemostatic evaluation in patients taking valproic acid: a retrospective cross-sectional study","volume":"17","author":"Post DS","year":"2022","unstructured":"Post DS, van der Veer A, Schijns OEMG, . Assessment of need for hemostatic evaluation in patients taking valproic acid: a retrospective cross-sectional study. PLoS One. 2022;17(2):e0264351."},{"issue":"2","key":"b18","series-title":"Can J Anaesth","first-page":"222","article-title":"Intraoperative defect in haemostasis in a child receiving valproic acid","volume":"38","author":"Tetzlaff JE","year":"1991","unstructured":"Tetzlaff JE. Intraoperative defect in haemostasis in a child receiving valproic acid. Can J Anaesth. 1991;38(2):222\u2013224."},{"issue":"1","key":"b19","series-title":"Epilepsia","first-page":"178","article-title":"Valproate therapy induces von Willebrand disease type I","volume":"33","author":"Kreuz W","year":"1992","unstructured":"Kreuz W, Linde R, Funk M, . Valproate therapy induces von Willebrand disease type I. Epilepsia. 1992;33(1):178\u2013184."},{"issue":"4","key":"b20","series-title":"Acta Neurol Belg","first-page":"97","article-title":"Levetiracetam and bleeding disorders","volume":"107","author":"Boon P","year":"2007","unstructured":"Boon P, Hulhoven R, Offner F. Levetiracetam and bleeding disorders. Acta Neurol Belg. 2007;107(4):97\u2013102."},{"key":"b21","series-title":"Front Pediatr","first-page":"589","article-title":"Clinical characteristics of hospitalized neonates with hypofibrinogenemia: a retrospective cohort study","volume":"8","author":"Zhou W","year":"2020","unstructured":"Zhou W, He Y, Li Q, Li Y, Su Y, Yan L. Clinical characteristics of hospitalized neonates with hypofibrinogenemia: a retrospective cohort study. Front Pediatr. 2020;8:589."},{"issue":"9","key":"b22","series-title":"J Clin Neurosci","first-page":"1180","article-title":"The effect of antiepileptic drugs on coagulation and bleeding in the perioperative period of epilepsy surgery: the Cleveland Clinic experience","volume":"18","author":"Manohar C","year":"2011","unstructured":"Manohar C, Avitsian R, Lozano S, Gonzalez-Martinez J, Cata JP. The effect of antiepileptic drugs on coagulation and bleeding in the perioperative period of epilepsy surgery: the Cleveland Clinic experience. J Clin Neurosci. 2011;18(9):1180\u20131184."},{"issue":"2","key":"b23","series-title":"J Neurosurg","first-page":"252","article-title":"Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment","volume":"87","author":"Anderson GD","year":"1997","unstructured":"Anderson GD, Lin YX, Berge C, Ojemann GA. Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment. J Neurosurg. 1997;87(2):252\u2013256."},{"issue":"1","key":"b24","series-title":"Epilepsia","first-page":"98","article-title":"Preoperative valproate administration does not increase blood loss during temporal lobectomy","volume":"37","author":"Ward MM","year":"1996","unstructured":"Ward MM, Barbaro NM, Laxer KD, Rampil IJ. Preoperative valproate administration does not increase blood loss during temporal lobectomy. Epilepsia. 1996;37(1):98\u2013101."},{"key":"b25","series-title":"Int J Surg","first-page":"156","article-title":"STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery","volume":"72","author":"Agha R","year":"2019","unstructured":"Agha R, Abdall-Razak A, Crossley E, Dowlut N, Iosifidis C, Mathew G. STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery. Int J Surg. 2019;72:156\u2013165."},{"issue":"2","key":"b26","series-title":"Brain Dev","first-page":"105","article-title":"Hematologic manifestations and impaired liver synthetic function during valproate monotherapy","volume":"18","author":"Hauser E","year":"1996","unstructured":"Hauser E, Seidl R, Freilinger M, Male C, Herkner K. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy. Brain Dev. 1996;18(2):105\u2013109."},{"issue":"3","key":"b27","series-title":"Epilepsia","first-page":"438","article-title":"Valproate-induced thrombocytopenia: a prospective monotherapy study","volume":"49","author":"Nasreddine W","year":"2008","unstructured":"Nasreddine W, Beydoun A. Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia. 2008;49(3):438\u2013445."},{"issue":"2","key":"b28","series-title":"Br J Clin Pharmacol","first-page":"329","article-title":"Population pharmacokinetics of a triple-secured fibrinogen concentrate administered to afibrinogenaemic patients: observed age- and body weight-related differences and consequences for dose adjustment in children","volume":"86","author":"Bellon A","year":"2020","unstructured":"Bellon A, Fuseau E, Roumanie O, . Population pharmacokinetics of a triple-secured fibrinogen concentrate administered to afibrinogenaemic patients: observed age- and body weight-related differences and consequences for dose adjustment in children. Br J Clin Pharmacol. 2020;86(2):329\u2013337."},{"key":"b29","series-title":"Front Pediatr","first-page":"617500","article-title":"Pediatric fibrinogen PART I\u2014Pitfalls in fibrinogen evaluation and use of fibrinogen replacement products in children","volume":"9","author":"Huisman EJ","year":"2021","unstructured":"Huisman EJ, Crighton GL. Pediatric fibrinogen PART I\u2014Pitfalls in fibrinogen evaluation and use of fibrinogen replacement products in children. Front Pediatr. 2021;9:617500."},{"key":"b30","series-title":"Front Pediatr","first-page":"647680","article-title":"Pediatric fibrinogen PART II\u2014Overview of indications for fibrinogen use in critically ill children","volume":"9","author":"Crighton GL","year":"2021","unstructured":"Crighton GL, Huisman EJ. Pediatric fibrinogen PART II\u2014Overview of indications for fibrinogen use in critically ill children. Front Pediatr. 2021;9:647680."},{"issue":"8","key":"b31","series-title":"Perfusion","first-page":"629","article-title":"Fibrinogen levels and postoperative chest drain blood loss in low-weight (<10 kg) children undergoing cardiac surgery","volume":"34","author":"Ranucci M","year":"2019","unstructured":"Ranucci M, Bianchi P, Cotza M, . Fibrinogen levels and postoperative chest drain blood loss in low-weight (<10 kg) children undergoing cardiac surgery. Perfusion. 2019;34(8):629\u2013636."},{"issue":"3","key":"b32","series-title":"J Pediatr Orthop","first-page":"283","article-title":"Is operative blood loss associated with valproic acid? Analysis of bilateral femoral osteotomy in children with total involvement cerebral palsy","volume":"25","author":"Carney BT","year":"2005","unstructured":"Carney BT, Minter CL. Is operative blood loss associated with valproic acid? Analysis of bilateral femoral osteotomy in children with total involvement cerebral palsy. J Pediatr Orthop. 2005;25(3):283\u2013285."},{"issue":"6","key":"b33","series-title":"J Pediatr Orthop","first-page":"792","article-title":"The effect of valproic acid on blood loss in patients with cerebral palsy","volume":"19","author":"Chambers HG","year":"1999","unstructured":"Chambers HG, Weinstein CH, Mubarak SJ, Wenger DR, Silva PD. The effect of valproic acid on blood loss in patients with cerebral palsy. J Pediatr Orthop. 1999;19(6):792\u2013795."},{"issue":"1","key":"b34","series-title":"Pediatr Neurol","first-page":"19","article-title":"Perioperative blood loss: the effect of valproate","volume":"15","author":"Winter SL","year":"1996","unstructured":"Winter SL, Kriel RL, Novacheck TF, Luxenberg MG, Leutgeb VJ, Erickson PA. Perioperative blood loss: the effect of valproate. Pediatr Neurol. 1996;15(1):19\u201322."},{"key":"b35","series-title":"Epilepsy Res","first-page":"191","article-title":"Valproic acid as an antiepileptic drug: is there a clinical relevance for the epilepsy surgeon?","volume":"127","author":"Kurwale N","year":"2016","unstructured":"Kurwale N, Garg K, Arora A, Chandra PS, Tripathi M. Valproic acid as an antiepileptic drug: is there a clinical relevance for the epilepsy surgeon? Epilepsy Res. 2016;127:191\u2013194."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/32\/5\/article-p527.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/32\/5\/article-p527.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/32\/5\/article-p527.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T12:59:50Z","timestamp":1733489990000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/32\/5\/article-p527.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":35,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2023.6.peds23196","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}